CDKN2A and cancer: Furthermore, our results are consistent with prior studies reporting robust ddPCR performance in cancer detection; for instance, an investigation into CDKN2A copy number variations in 57 FFPE melanoma samples yielded a sensitivity of 94.4% and a specificity of 90.0% [50].